BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Annexon, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:36 pm Purchase | 2024-09-30 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 9,027,778 8.400% | 2,027,778 (+28.97%) | Filing |
| 2024-02-14 10:26 am Purchase | 2023-12-31 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 7,000,000 8.900% | 3,219,306 (+85.15%) | Filing |
| 2023-02-13 6:00 pm Purchase | 2022-12-31 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 3,780,694 7.900% | 437,500 (+13.09%) | Filing |
| 2022-05-26 5:09 pm Purchase | 2022-05-16 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 3,343,194 8.700% | 3,343,194 (New Position) | Filing |